Overview

Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin

Status:
Active, not recruiting

Trial end date:
2024-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the impact of antibiotic therapy on the disease progression and overall survival of patients with Pseudomyxoma Peritonei (PMP).

Phase:

Phase 2

Details

Lead Sponsor:

Mercy Medical Center

Treatments:

Amoxicillin
Anti-Bacterial Agents
Antibiotics, Antitubercular
Clarithromycin
Dexlansoprazole
Lansoprazole